en

PRODUCT DETAIL

Teriflunomide MSN 14 mg filmom obalené tablety

Code 3373E
MA number 59/0092/23-S
Product Form: tbl flm 98x14 mg (blis.OPA/Al/PVC/Al-kalend.)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AA Selective immunosuppressants
L04AA31 Teriflunomide
Shelf life: 24
Container: blister OPA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 04.05.2023
Validity: 04.05.2028
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric warnings: Yes
SPC: SPC_Teriflunomide MSN 14 mg filmom obalené tablety_04 2023.pdf  
PIL: PIL_Teriflunomide MSN 14 mg filmom obalené tablety_04 2023.pdf  
Dokument: Teriflunomid_Karta pre pacienta.pdf  
Dokument: Teriflunomid_Pokyny pre zdravotnickych pracovnikov.pdf  
Safety feature Yes
Data update: 16.05.2023
eu-flag.png sk-flag.png